Imatinib Mesylate 67184-0533
Product NDC
67184-0533- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 21, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA212135
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 400 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(3)
30 TABLET in 1 BOTTLE (67184-0533-1)
300 TABLET in 1 BOTTLE (67184-0533-2)
30 BLISTER PACK in 1 CARTON (67184-0533-3) / 10 TABLET in 1 BLISTER PACK